Handelsavisen
prelaunch
Companies Healthcare 354200.KQ
35
354200.KQ KOSDAQ Medical Equipment, Supplies & Distribution

354200.Kq

$883,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-49,0 %
ROE
-24,1 %
Net margin
-26,1 %
Debt / equity
1,45
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-24,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 354200.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 354200.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.45, indicating a significant reliance on debt financing. Its liquidity position is weak, as evidenced by a current ratio of 0.51, suggesting that the company may struggle to meet its short-term obligations. The company's financial health is further compromised by a negative return on equity of -24.13% and a negative return on assets of -7.66%, both of which are far below the industry norms for profitability and asset utilization.

    The company's profitability is severely underperforming, with a net loss of KRW 5,542,217,240 and an operating loss of KRW 10,410,089,400. These figures indicate a significant deviation from the industry's preferred metrics, which typically emphasize positive operating margins and net profit margins. The company's gross profit of KRW 3,795,568,010 is insufficient to cover its operating expenses, leading to a substantial operating loss.

    The company's revenue is not segmented by geographic regions or business lines in the provided data, making it difficult to assess the geographic exposure or the contribution of different segments to the overall revenue. However, the lack of segmentation data suggests that the company may have a concentrated revenue base, which could pose a risk if a particular region or segment experiences a downturn.

    The company's growth trajectory is negative, with a significant decline in operating and net income. The outlook for the current fiscal year is not provided, but the historical performance indicates a challenging environment for the company. The negative operating cash flow of KRW -8,490,216,240 and a free cash flow of KRW -1,757,953,260 further underscore the company's financial distress.

    The company's risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt indicates that the company is not in a position to meet its debt obligations without additional financing. The dilution risk is low, suggesting that the company is not likely to issue additional shares in the near term to raise capital.

    Recent events and filings have not been provided in the input data, so it is not possible to comment on any specific recent developments that may have impacted the company's financial performance. However, the financial data suggests that the company is facing significant challenges that may require strategic interventions to stabilize its operations and improve its financial position.

    Key takeaways
    • The company is experiencing significant financial distress, as indicated by substantial net and operating losses.
    • The company's capital structure is highly leveraged, with a debt-to-equity ratio of 1.45.
    • The company's liquidity position is weak, with a current ratio of 0.51.
    • The company's profitability metrics are far below industry norms, with a negative return on equity of -24.13%.
    • The company's cash flow is negative, with a free cash flow of KRW -1,757,953,260.
    • "margin_outlook_rationale": "The company's margin outlook is negative due to the significant operating and net losses, which indicate a failure to maintain profitability.",

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $883,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $22.97B
    Net cash
    -$31.31B
    Current ratio
    0.5
    Debt / equity
    1.4
    ROA
    -7.7%
    ROE
    -24.1%
    Cash conversion
    153.0%
    CapEx / revenue
    -0.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-49,0 %Bottom quartile
    Net Margin-26,1 %Bottom quartile
    ROE-24,1 %Bottom quartile
    Capex / Rev-0,6 %Above P75
    D/E1,45Bottom quartile
    Cash Conv1,53Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 354200.KQ Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    354200.KQCanonical
    KOSDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage